Malathion

Scabies: UK facing unusually large outbreaks – and treatment shortages appear mostly to blame

Retrieved on: 
Freitag, Januar 5, 2024

Outbreaks happen regularly – with an estimated 450 million cases occurring globally each year.

Key Points: 
  • Outbreaks happen regularly – with an estimated 450 million cases occurring globally each year.
  • But since the start of winter, outbreaks in the UK have been higher than normal.
  • While there a probably a few factors that can explain this spike, treatment shortages appear to be at the heart of it.
  • The skin rash is also more severe, with a crust over the surface of the infected area.
  • Itching may take up to a month to completely subside after treatment.

Outbreak causes

  • This means mites spread more easily in places where people come into close contact with each other for extended periods of time – such as schools, universities and prisons.
  • Residential care and nursing homes are particularly high-risk settings for scabies outbreaks, with vulnerable populations and staff members alike at risk of infection.
  • Another factor in the outbreak could be stigma against having scabies, with many people claiming the disease is caused by being unclean or a lack of bathing.
  • In reality, there’s no good evidence about a lack of washing being a risk factor.
  • While some evidence suggests that scabies incidence is higher in the winter, in reality outbreaks can happen at any time of the year.
  • Since September 2023, there’s been a shortage of both permethrin and malathion in the UK due to supply issues.

Preventing infection

  • If anyone has symptoms that might be scabies or another skin infection, such as itching and a rash or skin wounds, these should be reported to a doctor or healthcare provider as early as possible.
  • This is especially important if they have potentially been in close contact with a known case.
  • Scabies outbreaks can be brought under control – but diagnosis and treatment as early as possible is required for that to happen.


Michael Head has previously received funding from the Bill & Melinda Gates Foundation and the UK Department for International Development, and currently receives funding from Research England and the UK Medical Research Foundation.

908 Devices Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations

Retrieved on: 
Mittwoch, November 9, 2022

The MX908 mass spec device from 908 Devices detects toxic pesticides--like Methamidophos--onsite at illegal marijuana growing operations. (Photo: Business Wire)

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221109005295/en/
    The MX908 mass spec device from 908 Devices detects toxic pesticides--like Methamidophos--onsite at illegal marijuana growing operations.
  • Despite marijuana being legal in 39 states for recreational or medicinal purposes, illegal marijuana growing operations on public lands continue to have a devastating impact.
  • MX908 operators who require this capability should contact their 908 Devices representative or [email protected] for additional information.
  • 908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications.

LINDA DUPREE, CHIEF EXECUTIVE OFFICER OF NCSOLUTIONS, ANNOUNCES RETIREMENT; ALAN MILES, BOARD CHAIR, TO BECOME NEW CEO

Retrieved on: 
Dienstag, Juli 26, 2022

Alan Miles, who has served as chair of the NCS Board of Directors, is replacing her as chief executive officer, effective immediately.

Key Points: 
  • Alan Miles, who has served as chair of the NCS Board of Directors, is replacing her as chief executive officer, effective immediately.
  • Dan Malmed, managing director of agency sales at Nielsen, will join NCS as chief revenue officer.
  • In related changes, Jamie Moldafsky, chief marketing and communications officer at Nielsen, will replace Miles as chair of the NCS Board while retaining her responsibilities at Nielsen.
  • Dupree, a nearly 30-year veteran of the advertising, research and marketing industries, joined NCS as CEO in April 2019 as the company's first female CEO.